Accretion Nutraveda Limited has issued a postal ballot notice seeking shareholder approval to enhance its borrowing limits to ₹500 crore and alter its Memorandum of Association. The e-voting period for these special resolutions runs from September 10, 2026, to October 9, 2026.

The company aims to secure adequate financial flexibility for business expansion, organic growth initiatives, and future funding requirements. The proposed borrowing limit represents an increase from the existing limit of ₹50 crore, calculated as an amount in excess of the aggregate of paid-up share capital, free reserves, and share premium.

Key Resolutions

Shareholders are being asked to approve five special resolutions through remote e-voting facilitated by Central Depository Services (India) Limited (CDSL). The key items include:

• Alteration of MOA: Expansion of object clauses to include broader activities in nutraceuticals, pharmaceuticals, healthcare services, and agricultural produce processing.
• Borrowing Limits: Enhancement of borrowing capacity under Section 180(1)(c) of the Companies Act, 2013, up to ₹500 crore in excess of capital and reserves.
• Creation of Charge: Authorization to create mortgages or charges on movable and immovable properties to secure borrowings.
• Loans to Subsidiaries: Approval to advance loans or provide guarantees to subsidiaries and group companies up to ₹100 crore under Section 185.
• Loans and Investments: Permission to give loans, guarantees, or make investments in other bodies corporate up to ₹100 crore under Section 186.

Voting Process

The cut-off date for determining voting rights is September 4, 2026. Members holding shares as on this date are eligible to vote. The e-voting module will be disabled after the deadline on October 9, 2026, at 5:00 pm.

The company stated that the alteration of the MOA does not involve any diversion of proceeds raised through its Initial Public Offer (IPO). Unutilised IPO proceeds will continue to be deployed strictly towards the original objects stated in the prospectus.

Accretion Nutraveda Limited Board of Directors approved alterations to the Memorandum of Association and increased borrowing limits during a meeting held on September 1, 2026. The resolutions seek to expand operational scope and financial flexibility.

The approvals are subject to shareholder consent through a postal ballot process and compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Postal Ballot Notice will be filed with stock exchanges and published on the company website.

Proposed Alterations to Memorandum of Association

The Board proposed altering Object Clause III of the MOA to broaden the company’s business activities. The changes involve inserting or substituting objects in Main Object Clause III(A) and adding new sub-clauses III(B)(58) to III(B)(69).

Expanded Main Objects

The revised main objects permit the company to engage in a wider range of healthcare and food-related activities:

• Manufacturing and trading nutraceuticals, dietary supplements, vitamins, Ayurvedic, Homeopathic, Unani, Allopathic, and herbal products.
• Dealing in pharmaceuticals, bulk drugs, intermediates, raw materials, and medical devices including diagnostic kits and surgical instruments.
• Establishing and operating hospitals, diagnostic centres, nursing homes, medical colleges, and research laboratories.
• Producing and distributing mineral waters, health foods, nutraceuticals, and consumer food items such as juices, pickles, energy drinks, and probiotic foods.
• Supporting sick funds and charitable organizations for providing medicines and healthcare products.

Additional Powers

The new sub-clauses grant powers necessary for furtherance of the main objects, including:

• Investing in shares, stocks, securities, bonds, and other financial instruments.
• Acquiring buildings, factories, machinery, and land for business operations.
• Conducting scientific and technical research through laboratories and workshops.
• Undertaking backward and forward integration, including contract farming and sourcing raw materials like herbs and botanical extracts.
• Cultivating agricultural produce and managing farms, orchards, and processing units.

Financial and Corporate Governance Approvals

The Board also approved several proposals related to financial flexibility and corporate governance under the Companies Act, 2013:

• Increasing borrowing limits under Section 180(1)(c) for raising loans, issuing debt securities, or debt instruments via private placement or public issue.
• Enhancing limits under Section 180(1)(a) for creating charges, mortgages, or hypothecation on movable and immovable properties in favour of banks and lenders.
• Advancing loans or providing guarantees to entities where directors may be interested, under Section 185.
• Granting loans, guarantees, and investments exceeding prescribed limits under Section 186.

These measures aim to strengthen the company’s capital structure and enable strategic investments while maintaining regulatory compliance.